Literature DB >> 21226887

miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.

Chun-Ju Yang1, Wilma Grace Shen, Chung-Ji Liu, Yun-Wen Chen, Hsuan-Hsuan Lu, Meng-Miao Tsai, Shu-Chun Lin.   

Abstract

BACKGROUNDS: MicroRNAs are small noncoding RNAs involved in posttranscriptional gene regulation, which play an important role in both physiological functioning and pathological progression. The miR-221/miR-222 microRNA family has been shown to be related to the neoplastic process in a number of different types of cancers; nevertheless, its function in oral squamous cell carcinoma (OSCC) remained uncertain.
MATERIALS AND METHODS: Paired OSCC and matched noncancerous oral mucosa were examined for miR-221/miR-222 expression using quantitative reverse-transcription PCR. Ectopic expression of miR-221/miR-222 by lentiviral infection was investigated to explore its in vitro and in vivo impact on the oncogenic phenotype and the expression of various target genes. The expression of Cip/Kip cell cycle regulator p27 in tumors was analyzed with immunohistochemistry.
RESULTS: The expression levels of miR-221 and miR-222 were highly correlated in OSCC. Increased miR-221/miR-222 expression was found in 40% of OSCC tissues. The ectopic expression of miR-221 or of miR-222 increased growth and anchorage-independent colony formation of OSCC cell lines. It also resulted in an increase in the tumorigenesis of an OSCC cell line in nude mice. Western blot analysis suggested that p27 and p57 might be the targets of miR-221/miR-222. p27 expression was reversely associated with the miR-221 and miR-222 expression level in OSCC tissues.
CONCLUSIONS: Our findings suggested that increased miR-221/miR-222 expression was associated with the OSCC cell growth.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226887     DOI: 10.1111/j.1600-0714.2010.01005.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  23 in total

Review 1.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

2.  miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.

Authors:  Michaela Angelika Ihle; Marcel Trautmann; Helen Kuenstlinger; Sebastian Huss; Carina Heydt; Jana Fassunke; Eva Wardelmann; Sebastian Bauer; Hans-Ulrich Schildhaus; Reinhard Buettner; Sabine Merkelbach-Bruse
Journal:  Mol Oncol       Date:  2015-04-10       Impact factor: 6.603

3.  Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Authors:  Jian-Jun Zhao; Zhang-Bo Chu; Yu Hu; Jianhong Lin; Zhongqiu Wang; Meng Jiang; Ming Chen; Xujun Wang; Yue Kang; Yangsheng Zhou; Triona Ni Chonghaile; Melanie E Johncilla; Yu-Tzu Tai; Jin Q Cheng; Antony Letai; Nikhil C Munshi; Kenneth C Anderson; Ruben D Carrasco
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

4.  Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.

Authors:  Shaan Sarkar; Hala Dubaybo; Shadan Ali; Priscila Goncalves; Sri Lakshmi Kollepara; Seema Sethi; Philip A Philip; Yiwei Li
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

5.  Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients.

Authors:  Ana L Teixeira; Marta Ferreira; Joana Silva; Mónica Gomes; Francisca Dias; Juliana I Santos; Joaquina Maurício; Francisco Lobo; Rui Medeiros
Journal:  Tumour Biol       Date:  2013-12-31

6.  Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.

Authors:  Shuqi He; Renfa Lai; Dan Chen; Wangxiang Yan; Zhaoqiang Zhang; Zhiguo Liu; Xueqiang Ding; Yu Chen
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  MicroRNAs as potential therapeutics for treating spinal cord injury.

Authors:  Hualin Yan; Peiwei Hong; Mei Jiang; Hedong Li
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

8.  miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1.

Authors:  Chaoyang Sun; Na Li; Bo Zhou; Zongyuan Yang; Dong Ding; Danhui Weng; Li Meng; Shixuan Wang; Jianfeng Zhou; Ding Ma; Gang Chen
Journal:  Oncol Lett       Date:  2013-06-13       Impact factor: 2.967

9.  EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma.

Authors:  Wen-Cheng Lu; Shou-Yen Kao; Cheng-Chieh Yang; Hsi-Feng Tu; Cheng-Hsien Wu; Kuo-Wei Chang; Shu-Chun Lin
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

Review 10.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Authors:  Erika Larrea; Carla Sole; Lorea Manterola; Ibai Goicoechea; María Armesto; María Arestin; María M Caffarel; Angela M Araujo; María Araiz; Marta Fernandez-Mercado; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.